SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 124 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,102,742 | -35.6% | 1,060,140 | -0.8% | 0.00% | -50.0% |
| Q2 2023 | $6,366,395 | +79.9% | 1,068,187 | -1.3% | 0.00% | +100.0% |
| Q1 2023 | $3,539,592 | -14.9% | 1,082,444 | +2.8% | 0.00% | 0.0% |
| Q4 2022 | $4,157,659 | -15.3% | 1,052,572 | +28.7% | 0.00% | -50.0% |
| Q3 2022 | $4,908,000 | +0.1% | 818,023 | +7.3% | 0.00% | 0.0% |
| Q2 2022 | $4,904,000 | -22.7% | 762,616 | -0.7% | 0.00% | 0.0% |
| Q1 2022 | $6,347,000 | -45.1% | 768,344 | +2.8% | 0.00% | -33.3% |
| Q4 2021 | $11,565,000 | -31.8% | 747,114 | -0.7% | 0.00% | -40.0% |
| Q3 2021 | $16,949,000 | +77.5% | 752,613 | +54.9% | 0.01% | +66.7% |
| Q2 2021 | $9,551,000 | -41.4% | 485,784 | -0.3% | 0.00% | -40.0% |
| Q1 2021 | $16,305,000 | – | 487,166 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $220,158,000 | 8.29% |
| Crestline Management, LP | 3,365,624 | $21,641,000 | 2.82% |
| Omega Fund Management, LLC | 843,750 | $5,425,000 | 1.73% |
| Alphabet Inc. | 2,812,500 | $18,084,000 | 0.98% |
| HARVARD MANAGEMENT CO INC | 468,749 | $3,014,000 | 0.35% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 6,400,000 | $41,152,000 | 0.35% |
| PFM Health Sciences, LP | 952,733 | $6,126,000 | 0.23% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 156,254 | $1,005,000 | 0.20% |
| Viewpoint Capital Management LLC | 23,545 | $151,000 | 0.14% |
| Artal Group S.A. | 400,000 | $2,572,000 | 0.14% |